Thus, we consider that people with >25 U/L of ALT in women, >30 U/L of ALT in men and/or AST<ALT within the normal range of ALT with a BMI of >25 kg/m2 are candidates for receiving NAFLD screening. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.